<p><span ><strong><u>CARCINOMA OF PROSTATE</u></strong></span></p><p style="margin-left:0cm;text-align:justify;"><span >Ninety-five per&nbsp; cent&nbsp; of&nbsp;these&nbsp; tumours&nbsp; are&nbsp;adenocarcinomas.&nbsp; The majority of men affected are aged between 65 and 85 years. The incidence&nbsp;increases with&nbsp;age.&nbsp;It&nbsp;is&nbsp;recommended&nbsp;that&nbsp;every&nbsp;male,&nbsp;40&nbsp;years and above, should have annual screening by Prostate Specific Antigen (PSA) tests and Digital Rectal Examination (DRE) since early detection is associated with better prognosis. The benefit or otherwise of screening should be discussed with&nbsp;patients.</span> <span >Patients&nbsp;with&nbsp;a&nbsp;family&nbsp;history of&nbsp;prostate&nbsp;cancer and&nbsp;should&nbsp;consider annual screening from 40 years and above with PSA and DRE. It is worth noting that not every hard prostate on DRE is malignant. Likewise a normal-feeling&nbsp;prostate&nbsp;does&nbsp;not&nbsp;exclude a&nbsp;malignancy.&nbsp;A&nbsp;prostatic&nbsp;biopsy is therefore necessary to establish a&nbsp;diagnosis.</span></p><h3 style="margin-left:0cm;">CAUSES</h3><ul><li>Ageing</li><li>Functional&nbsp;testes</li><li>Family&nbsp;history of&nbsp;prostate&nbsp;cancer,&nbsp;breast cancer,&nbsp;ovarian cancer</li><li>Race (more common in&nbsp;blacks)</li><li>High dietary fat&nbsp;intake</li></ul><h3 style="margin-left:0cm;">SYMPTOMS</h3><ul><li>Asymptomatic:&nbsp;prostate cancer&nbsp;may&nbsp;be&nbsp;present&nbsp;without symptoms in the early&nbsp;stage</li><li>Lower Urinary Tract&nbsp;Symptoms (LUTS) and&nbsp;IPSS</li><li>Retention of&nbsp;urine</li><li>Haematuria</li><li>General&nbsp;debility anorexia,&nbsp;weight&nbsp;loss,&nbsp;listlessness</li><li>Bone pain (commonly in the waist or&nbsp;limbs)</li><li>Paralysis in the lower limbs or inability to&nbsp;walk</li><li>Pathological&nbsp;Fracture</li><li>Impotence</li><li>Haemospermia</li><li>Tenesmus</li></ul><h3 style="margin-left:0cm;">SIGNS</h3><p><strong>On DRE clinical signs include;</strong></p><ul><li>Hard&nbsp;prostate gland&nbsp;with&nbsp;an&nbsp;irregular&nbsp;surface and&nbsp;edges</li><li>Obliterated median&nbsp;sulcus</li><li>Adherent rectal&nbsp;mucosa</li></ul><h3 style="margin-left:0cm;">Advanced or metastatic disease:</h3><ul><li>Anaemia</li><li>Uraemia</li><li>Wasting</li><li>Bone&nbsp;tenderness</li><li>Paraplegia</li><li>Pathological&nbsp;fracture</li></ul><h3 style="margin-left:0cm;">INVESTIGATIONS</h3><ul><li>FBC</li><li>Blood urea, electrolytes and&nbsp;creatinine</li><li>Prostate Specific Antigen&nbsp;(PSA)</li><li>Liver function&nbsp;tests</li><li>Abdominal and pelvic&nbsp;ultrasound</li><li>Transrectal&nbsp;Ultrasound&nbsp;(TRUS)&nbsp;of&nbsp;the&nbsp;prostate,&nbsp;if&nbsp;available</li><li>Transrectal&nbsp;needle biopsy&nbsp;of&nbsp;the&nbsp;prostate</li><li>TRUS-guided or&nbsp;finger-guided</li></ul><h3 style="margin-left:0cm;">TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To relieve&nbsp;symptoms</li><li>To control&nbsp;complications</li><li>To achieve cure for early disease</li><li>To prevent local progression and&nbsp;metastases</li></ul><h3 style="margin-left:0cm;">Non-pharmacological treatment</h3><ul><li>Urethral&nbsp;catheterisation&nbsp;to&nbsp;relieve&nbsp;urinary retention&nbsp;where&nbsp;needed</li><li>Radical prostatectomy or radiotherapy, under specialist care,&nbsp;for&nbsp;early disease</li><li>Surgical&nbsp;castration&nbsp;(bilateral&nbsp;orchidectomy)&nbsp;for&nbsp;advanced&nbsp;disease</li></ul><h3 style="margin-left:0cm;">Pharmacological treatment</h3><p style="margin-left:0cm;"><span >Evidence Rating: [A]</span></p><ul><li>Pharmacological treatment of carcinoma of the prostate,&nbsp;which involves hormonal manipulation, which inhibits growth of the tumour by depriving it of androgens, is best carried out under specialist care.</li><li>The&nbsp;common&nbsp;drugs&nbsp;used&nbsp;in&nbsp;advanced prostate&nbsp;cancer&nbsp;therapy are:</li></ul><ol><li><span >Antiandrogens</span></li></ol><ul><li>Bicalutamide,&nbsp;oral,&nbsp;50&nbsp;mg&nbsp;daily&nbsp;(refer to&nbsp;specialist)</li></ul><h3 style="margin-left:0cm;">Or</h3><ul><li>Flutamide,&nbsp;oral,&nbsp;250&nbsp;mg&nbsp;8&nbsp;hourly(refer&nbsp;to&nbsp;specialist)</li></ul><ol><li><span >Oestrogen</span></li></ol><ul><li>Stilboestrol,&nbsp;oral,&nbsp;2-5&nbsp;mg&nbsp;daily&nbsp;(Avoid&nbsp;in clients&nbsp;with&nbsp;cardiovascular diseases), (refer to&nbsp;specialist)</li></ul><p style="margin-left:0cm;">&nbsp;</p><ol><li><span >LHRH Analogues</span></li></ol><ul><li>Goserelin,&nbsp;SC,&nbsp;preferably&nbsp;in&nbsp;the&nbsp;abdominal&nbsp;wall&nbsp;(refer&nbsp;to&nbsp;specialist)</li></ul><h3 style="margin-left:0cm;">Or</h3><ul><li>Leuprolide&nbsp;acetate, IM,&nbsp;(refer&nbsp;to&nbsp;specialist)</li></ul><h3 style="margin-left:0cm;">And</h3><ul><li>Bisphosphonates&nbsp;and&nbsp;Fentanyl&nbsp;patches(refer&nbsp;to&nbsp;specialist)</li></ul><p>&nbsp;</p><h3 style="margin-left:0cm;">REFERRAL CRITERIA</h3><p><span >Refer all cases to a specialist centre for evaluation and management</span></p>